Prevalence and correlates of paediatric guideline non-adherence for initial empirical care in six low and middle-income settings: a hospital-based cross-sectional study

OBJECTIVES

This study evaluated the prevalence and correlates of guideline non-adherence for common childhood illnesses in low-resource settings.

DESIGN AND SETTING

We used secondary cross-sectional data from eight healthcare facilities in six Asian and African countries.

PARTICIPANTS

A total of 2796 children aged 2-23 months hospitalised between November 2016 and January 2019 with pneumonia, diarrhoea or severe malnutrition (SM) and without HIV infection were included in this study.

PRIMARY OUTCOME MEASURES

We identified children treated with full, partial or non-adherent initial inpatient care according to site-specific standard-of-care guidelines for pneumonia, diarrhoea and SM within the first 24 hours of admission. Correlates of guideline non-adherence were identified using generalised estimating equations.

RESULTS

Fully adherent care was delivered to 32% of children admitted with diarrhoea, 34% of children with pneumonia and 28% of children with SM when a strict definition of adherence was applied. Non-adherence to recommendations was most common for oxygen and antibiotics for pneumonia; fluid, zinc and antibiotics for diarrhoea; and vitamin A and zinc for SM. Non-adherence varied by site. Pneumonia guideline non-adherence was more likely among patients with severe disease (OR 1.82; 95% CI 1.38, 2.34) compared with non-severe disease. Diarrhoea guideline non-adherence was more likely among lower asset quintile groups (OR 1.16; 95% CI 1.01, 1.35), older children (OR 1.10; 95% CI 1.06, 1.13) and children presenting with wasting (OR 6.44; 95% CI 4.33, 9.57) compared with those with higher assets, younger age and not wasted.

CONCLUSIONS

Non-adherence to paediatric guidelines was common and associated with older age, disease severity, and comorbidities, and lower household economic status. These findings highlight opportunities to improve guidelines by adding clarity to specific recommendations.

Evaluating blood culture collection practice in children hospitalized with acute illness at a tertiary hospital in Malawi

BACKGROUND

Blood culture collection practice in low-resource settings where routine blood culture collection is available has not been previously described.

METHODOLOGY

We conducted a secondary descriptive analysis of children aged 2-23 months enrolled in the Malawi Childhood Acute Illness and Nutrition (CHAIN) study, stratified by whether an admission blood culture had been undertaken and by nutritional status. Chi-square test was used to compare the differences between groups.

RESULTS

A total of 347 children were included, of whom 161 (46%) had a blood culture collected. Children who had a blood culture collected, compared to those who did not, were more likely to present with sepsis (43% vs. 20%, p < 0.001), gastroenteritis (43% vs. 26%, p < 0.001), fever (86% vs. 73%, p = 0.004), and with poor feeding/weight loss (30% vs. 18%, p = 0.008). In addition, hospital stay in those who had a blood culture was, on average, 2 days longer (p = 0.019). No difference in mortality was observed between those who did and did not have a blood culture obtained.

CONCLUSION

Blood culture collection was more frequent in children with sepsis and gastroenteritis, but was not associated with mortality. In low-resource settings, developing criteria for blood culture based on risk factors rather than clinician judgement may better utilize the existing resources.

A262 NEONATAL ACUTE LIVER FAILURE DUE TO PRESUMED GESTATIONAL ALLOIMMUNE LIVER DISEASE - A CASE REPORT

Background

Neonatal acute liver failure (NALF) is a rare disease that is distinct from acute liver failure seen in older children and adults. Gestational alloimmune liver disease (GALD) is the most frequent cause, is initiated in utero by sensitization of the maternal immune system to a fetal hepatocyte antigen and subsequent production of maternal immunoglobulin G antibodies that cross the placenta. Maternal IgG binds to a fetal hepatocyte antigen and initiates an innate immune response involving the terminal complement cascade and membrane attach complex. The understanding of the alloimmune origin has led to the use of intravenous immunoglobulin (IVIG) treatment and exchange transfusion, significantly increasing survival. However, approximately 25% of patients may not respond and require salvage liver transplantation. In spite of an increased rate of comorbidities, concern for technical difficulties and limited graft availability, young infants eligible for transplant have been shown to have similar overall patient and graft survival rates compared to older children with other indications for liver transplant.

Purpose

The primary aim of our study is to report a case of NALF with successful liver transplant.

Method

We present the case of a preterm girl with NALF due to GALD refractory to medical management, requiring liver transplantation.

Result(s)

This is a 35-week preterm girl, with scant pre-natal care, birth weight of 1.825 kg and Apgar 9/9. She is the seventh child of non-consanguineous parents, with healthy siblings. On day-of-life (DOL) 1 she presented with acute kidney injury, progressive worsening metabolic acidosis and hyperammonemia and was found to be profoundly coagulopathic (INR 6), with normal liver enzymes and liver failure was diagnosed. Initial investigation ruled out congenital infections, sepsis, neonatal hemophagocytic lymphohistiocytosis and metabolic diseases. Magnetic resonance imaging of the body demonstrated findings in keeping with iron deposition in the thyroid, liver and pancreas, suggestive of GALD. Completed double volume exchange transfusion and IVIG on DOL 9 and repeat IVIG on DOL 13 and 15, with partial improvement in INR. Due to persistent ascites, conjugated hyperbilirubinemia and hyperammonemia she was transferred for urgent liver transplant assessment. Persistent liver dysfunction in the form of hyperammonemia, hypoglycemia and progressive coagulopathy led to transplant listing on DOL 30. ABO incompatible deceased donor liver transplant was completed on DOL 62 (4.075 kg, estimated dry weight 3.5 kg). The procedure was uncomplicated, liver enzymes normalized, coagulopathy and hypoglycemia resolved. She was transferred to the ward on post-operative day (POD) 6. and weaned off sedatives and transitioned to oral feeds within 2 weeks of transplant, with complex abdominal wound closure on POD 29.

Conclusion(s)

Successful liver transplantation is possible in neonates with acute liver failure due to GALD refractory to medical management and weighing 4kg or less.

Please acknowledge all funding agencies by checking the applicable boxes below

None

Disclosure of Interest

None Declared

MICROBIOME & MICROBIAL THERAPY

The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia

Introduction: Many acutely ill children in low- and middle-income settings have a high risk of mortality both during and after hospitalisation despite guideline-based care. Understanding the biological mechanisms underpinning mortality may suggest optimal pathways to target for interventions to further reduce mortality. The Childhood Acute Illness and Nutrition (CHAIN) Network ( www.chainnnetwork.org) Nested Case-Cohort Study (CNCC) aims to investigate biological mechanisms leading to inpatient and post-discharge mortality through an integrated multi-omic approach. Methods and analysis; The CNCC comprises a subset of participants from the CHAIN cohort (1278/3101 hospitalised participants, including 350 children who died and 658 survivors, and 270/1140 well community children of similar age and household location) from nine sites in six countries across sub-Saharan Africa and South Asia. Systemic proteome, metabolome, lipidome, lipopolysaccharides, haemoglobin variants, toxins, pathogens, intestinal microbiome and biomarkers of enteropathy will be determined. Computational systems biology analysis will include machine learning and multivariate predictive modelling with stacked generalization approaches accounting for the different characteristics of each biological modality. This systems approach is anticipated to yield mechanistic insights, show interactions and behaviours of the components of biological entities, and help develop interventions to reduce mortality among acutely ill children. Ethics and dissemination. The CHAIN Network cohort and CNCC was approved by institutional review boards of all partner sites. Results will be published in open access, peer reviewed scientific journals and presented to academic and policy stakeholders. Data will be made publicly available, including uploading to recognised omics databases. Trial registration NCT03208725.

Neurodevelopment and Recovery From Wasting

BACKGROUND AND OBJECTIVES

Acute illness with malnutrition is a common indication for hospitalization among children in low- and middle-income countries. We investigated the association between wasting recovery trajectories and neurodevelopmental outcomes in young children 6 months after hospitalization for an acute illness.

METHODS

Children aged 2 to 23 months were enrolled in a prospective observational cohort of the Childhood Acute Illness &amp; Nutrition Network, in Uganda, Malawi, and Pakistan between January 2017 and January 2019. We grouped children on the basis of their wasting recovery trajectories using change in mid-upper arm circumference for age z-score. Neurodevelopment was assessed with the Malawi Developmental Assessment Tool (MDAT development-for-age z-score [DAZ]) at hospital discharge and after 6 months.

RESULTS

We included 645 children at hospital discharge (mean age 12.3 months ± 5.5; 55% male); 262 (41%) with severe wasting, 134 (21%) with moderate wasting, and 249 (39%) without wasting. Four recovery trajectories were identified: high-stable, n = 112; wasted-improved, n = 404; severely wasted-greatly improved, n = 48; and severely wasted-not improved, n = 28. The children in the severely wasted-greatly improved group demonstrated a steep positive MDAT-DAZ recovery slope. This effect was most evident in children with both wasting and stunting (interaction wasted-improved × time × stunting: P &lt; .001). After 6 months, the MDAT DAZ in children with wasting recovery did not differ from community children. In children who never recovered from wasting, there remained a significant delay in MDAT DAZ scores.

CONCLUSIONS

Neurodevelopment recovery occurred in parallel with wasting recovery in children convalescing from acute illness and was influenced by stunting.

The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia

Introduction: Many acutely ill children in low- and middle-income settings have a high risk of mortality both during and after hospitalisation despite guideline-based care. Understanding the biological mechanisms underpinning mortality may suggest optimal pathways to target for interventions to further reduce mortality. The Childhood Acute Illness and Nutrition (CHAIN) Network ( www.chainnnetwork.org) Nested Case-Cohort Study (CNCC) aims to investigate biological mechanisms leading to inpatient and post-discharge mortality through an integrated multi-omic approach. Methods and analysis; The CNCC comprises a subset of participants from the CHAIN cohort (1278/3101 hospitalised participants, including 350 children who died and 658 survivors, and 270/1140 well community children of similar age and household location) from nine sites in six countries across sub-Saharan Africa and South Asia. Systemic proteome, metabolome, lipidome, lipopolysaccharides, haemoglobin variants, toxins, pathogens, intestinal microbiome and biomarkers of enteropathy will be determined. Computational systems biology analysis will include machine learning and multivariate predictive modelling with stacked generalization approaches accounting for the different characteristics of each biological modality. This systems approach is anticipated to yield mechanistic insights, show interactions and behaviours of the components of biological entities, and help develop interventions to reduce mortality among acutely ill children. Ethics and dissemination. The CHAIN Network cohort and CNCC was approved by institutional review boards of all partner sites. Results will be published in open access, peer reviewed scientific journals and presented to academic and policy stakeholders. Data will be made publicly available, including uploading to recognised omics databases. Trial registration NCT03208725.

Predictors of Weight Gain in Under Five Children With Severe Acute Malnutrition: An Analysis of the Icddr, B Hospital Dataset

Objectives

Children admitted to hospital with severe acute malnutrition (SAM) and acute illness can be challenging to nutritionally rehabilitate. There is limited understanding on predictors of weight gain during hospitalization in this vulnerable population. This work aimed to predict the weight gain in children using anthropometric, biochemical, clinical, and socio-demographic variables.

Methods

We included 5,044 children aged 0–59 months with SAM hospitalized in the Dhaka Hospital at icddr, b between 2011 and 2019. Surveillance data was collected during hospitalization and analyzed retrospectively. The 15% weight gain from hospital admission to discharge was considered as outcome because it is recommended as the transition criteria from facility to community-based management. We trained a Random Forest classifier to identify the best set of predictors of a 15% weight gain. A total of 78 features were considered. The developed diagnostic model was validated based on the area under the curve (AUC) between the true positive and the false positive rates.

Results

The classification of data based on the outcome (weight gain > 15%) created unbalanced classes, a larger group with < 15% changes in weight and a very small group with > 15% weight gain. To balance this data disparity, we finally included 263 children in this analysis. A model including 197 children (75% of the dataset) was identified in the training dataset, while the rest were used as a test dataset. Validation in the test dataset revealed an AUC of 69.05% when considering all 78 predictors. Among the top predictors were mid-upper arm circumference at admission, family income and breastfeeding duration.

Conclusions

This analysis revealed the role of socio-economic status as well as the importance of breastfeeding practices in attaining 15% weight gain from hospital admission to discharge in under five children treated for SAM. This finding has important implications for future work regarding childhood feeding practices and community-based detection of children with SAM.

Funding Sources

Joannah and Brian Lawson Center for Child Nutrition, Ontario Graduate Scholarship, Canadian Institutes of Health Research Healthy Cities Research Initiative, and icddr, b, Dhaka, Bangladesh.

The Association between Longitudinal BMI Patterns in Children and their Parents

Objectives

Parental (maternal and paternal) weight before and after pregnancy has been associated with an increased risk of obesity in the offspring. However, less is known on the longitudinal association between parental and child growth trajectories across early childhood. This work aims to describe parental and child body mass index (BMI) trajectory patterns from birth until adolescence and assess their association.

Methods

We analyzed 1537 single-child families participating in the Applied Research Group for Kids (TARGet Kids! ) cohort (ON, Canada). Children and their parents had repeated measurements of weight and length or height from child's birth to 13 years during scheduled visits with their primary care physician. These measurements were used to calculate BMI for parents and age and sex adjusted BMI z-scores (zBMI) for children based on the World Health Organization. Latent class mixed modeling was used to identify children and parental growth patterns. A loglinear analysis was conducted to study the tri-party interaction between child, maternal, paternal longitudinal patterns. Jaccard distance was used to assess cluster similarity.

Results

We identified two distinct patterns in children (normal, increasing obesity), mothers (normal, increasing obesity), and fathers (overweight, obesity). The three-way loglinear analysis indicated that the tri-party interaction between children, maternal and paternal growth patterns interaction was significant (χ2 (1) = 15.1, p < .001). 92.1% of children in the normal pattern had mothers in the normal pattern and fathers in the overweight pattern. Cluster similarity was 63% for mothers and children, but 12.5% between fathers and children, with most children from the increasing obesity group with a father in the overweight group.

Conclusions

There is a significant tri-party association between children, maternal and paternal BMI patterns from birth to adolescence. Future studies should aim in studying eating and other health behaviors associated with these relationships at the family level.

Funding Sources

Joannah and Brian Lawson Center for Child Nutrition, Ontario Graduate Scholarship, Canadian Institutes of Health Research.

Association between gut MIcrobiota, GROWth and Diet in peripubertal children from the TARGet Kids! cohort (The MiGrowD) study: protocol for studying gut microbiota at a community-based primary healthcare setting

INTRODUCTION

The gut microbiota interacts with diet to affect body health throughout the life cycle. Critical periods of growth, such as infancy and puberty, are characterised by microbiota remodelling and changes in dietary habits. While the relationship between gut microbiota and growth in early life has been studied, our understanding of this relationship during puberty remains limited. Here, we describe the MIcrobiota, GROWth and Diet in peripubertal children (The MiGrowD) study, which aims to assess the tripartite growth-gut microbiota-diet relationship at puberty.

METHODS AND ANALYSIS

The MiGrowD study will be a cross-sectional, community-based study involving children 8-12 years participating in the TARGet Kids!

COHORT

TARGet Kids! is a primary healthcare practice-based research network in Canada. Children will be asked to provide a stool sample, complete two non-consecutive 24-hour dietary recalls and a pubertal self-assessment based on Tanner Stages. Anthropometry will also be conducted. The primary outcome is the association between gut microbiota composition and longitudinal growth from birth until entry into the study. Anthropometrics data from birth will be from the data collected prospectively through TARGet Kids!. Body mass index z-scores will be calculated according to WHO. The secondary outcome is the association between gut microbiota, diet and pubertal stage.

ETHICS AND DISSEMINATION

Ethics approval has been obtained by the Hospital for Sick Children and St. Michael's Hospital-Unity Health, and the University of Toronto. Results will be disseminated in the public and academic sector, including participants, TARGet Kids! primary healthcare physicians teams, scientists via participation in the TARGet Kids! science and physician meetings, conferences and publications in peer-reviewed journals. The MiGrowD study results will help researchers understand the relationships underlying growth, gut microbiota and pubertal maturation in children.

The role of albumin and the extracellular matrix on the pathophysiology of oedema formation in severe malnutrition

BACKGROUND

While fluid flows in a steady state from plasma, through interstitium, and into the lymph compartment, altered fluid distribution and oedema can result from abnormal Starling's forces, increased endothelial permeability or impaired lymphatic drainage. The mechanism of oedema formation, especially the primary role of hypoalbuminaemia, remains controversial. Here, we explored the roles of albumin and albumin-independent mechanisms in oedema formation among children with severe malnutrition (SM).

METHODS

We performed secondary analysis of data obtained from two independent clinical trials in Malawi and Kenya (NCT02246296 and NCT00934492). We then used an unconventional strategy of comparing children with kwashiorkor and marasmus by matching (discovery cohort, n = 144) and normalising (validation cohort, n = 98, 2 time points) for serum albumin. Untargeted proteomics was used in the discovery cohort to determine plausible albumin-independent mechanisms associated with oedema, which was validated using enzyme-linked immunosorbent assay and multiplex assays in the validation cohort.

FINDINGS

We demonstrated that low serum albumin is necessary but not sufficient to develop oedema in SM. We further found that markers of extracellular matrix (ECM) degradation rather than markers of EG degradation distinguished oedematous and non-oedematous children with SM.

INTERPRETATION

Our results show that oedema formation has both albumin-dependent and independent mechanisms. ECM integrity appears to have a greater role in oedema formation than EG shedding in SM.

FUNDING

Research Foundation Flanders (FWO), Thrasher Foundation (15122 and 9403), VLIR-UOS-Ghent University Global Minds Fund, Bill & Melinda Gates Foundation (OPP1131320), MRC/DfID/Wellcome Trust Global Health Trials Scheme (MR/M007367/1), Canadian Institutes of Health Research (156307), Wellcome Trust (WT083579MA).

Canadian Nationwide Survey on Pediatric Malnutrition Management in Tertiary Hospitals

Background: Disease-associated malnutrition (DAM) is common in hospitalized children. This survey aimed to assess current in-hospital practices for clinical care of pediatric DAM in Canada. Methods: An electronic survey was sent to all 15 tertiary pediatric hospitals in Canada and addressed all pillars of malnutrition care: screening, assessment, treatment, monitoring and follow-up. Results: Responses of 120 health care professionals were used from all 15 hospitals; 57.5% were medical doctors (MDs), 26.7% registered dietitians (RDs) and 15.8% nurses (RNs). An overarching protocol for prevention, detection and intervention of pediatric malnutrition was present or “a work in progress”, according to 9.6% of respondents. Routine nutritional screening on admission was sometimes or always performed, according to 58.8%, although the modality differed among hospitals and profession. For children with poor nutritional status, lack of nutritional follow-up after discharge was reported by 48.5%. Conclusions: The presence of a standardized protocol for the clinical assessment and management of DAM is uncommon in pediatric tertiary care hospitals in Canada. Routine nutritional screening upon admission has not been widely adopted. Moreover, ongoing nutritional care of malnourished children after discharge seems cumbersome. These findings call for the adoption and implementation of a uniform clinical care pathway for malnutrition among pediatric hospitals.

Treating high-risk moderate acute malnutrition using therapeutic food compared with nutrition counseling (Hi-MAM Study): a cluster-randomized controlled trial

BACKGROUND

There is a lack of consensus on what is the most appropriate treatment of moderate acute malnutrition (MAM).

OBJECTIVES

We aimed to determine if provision of ready-to-use-therapeutic food (RUTF) and antibiotics to "high-risk" MAM (HR-MAM) children in addition to nutritional counseling would result in higher recovery and less deterioration than nutrition counseling alone.

METHODS

At the 11 intervention clinics, HR-MAM children were given RUTF and amoxicillin along with standard nutrition counseling, for 2-12 wk. All others received 6 wk of nutrition counseling alone. HR-MAM was defined as midupper arm circumference (MUAC) <11.9 cm, weight-for-age z score (WAZ) <-3.5, mother not the main caregiver, or a child <2 y old not being breastfed. Outcomes were compared using intention-to-treat analysis.

RESULTS

Analysis included 573 children at the intervention sites and 714 children at the control sites. Of the intervention group, 317 (55%) were classified as HR-MAM. Short-term recovery was greater at the intervention sites [48% compared with 39% at week 12; risk difference (rd): 0.08; 95% CI: 0.03, 0.13]. The intervention group had lower risk of deteriorating to severe acute malnutrition (SAM) (18% compared with 24%; rd: -0.07; 95% CI: -0.11, -0.04), lower risk of dying (1.8% compared with 3.1%; rd: -0.02; 95% CI: -0.03, -0.00), and greater gains in MUAC and weight than did children at the control sites. However, by 24 wk, the risk of SAM was similar between the 2 arms (31% compared with 34%; rd: -0.03; 95% CI: -0.09, 0.02). Control group data identified recent illness, MUAC <12.0 cm, WAZ <-3, dropping anthropometry, age <12 mo, being a twin, and a history of previous SAM as risk factors for deterioration.

CONCLUSIONS

Provision of RUTF and antibiotics to HR-MAM children improved short-term recovery and reduced short-term risk of deterioration. However, recovery rates were still suboptimal and differences were not sustained by 6 mo post enrollment.This trial was registered at clinicaltrials.gov as NCT03647150.

Outlier Detection in Growth Data: Beyond Biologically Implausible Values

Objectives

Eliminating anthropometry measurement error and employing outlier and biological implausible values (BIV) detection methods adapted to longitudinal measurements is important for the study of growth. This work aimed to review and assess the accuracy of the available BIV and outlier detection methods and propose a growth trajectory outlier detection method.

Methods

We included 2354 infants from the Applied Research Group for Kids (TARGet Kids! ) cohort-based in Toronto (ON, Canada) that recruits healthy children from birth to 5 years of age. We considered infants with at least 8 length and weight measurements available between the 1st and the 24th month of age. Weight-for-length z-scores (wflz) were calculated using the WHO growth standards. Outlier measurements were randomly introduced in 5% of the wflz measurements using a normal distribution (μ = 0, σ = 1). We employed 4 outlier detection methods; an empirical detection method for BIV using the cut-offs derived from the WHO Child Growth Standards, a clustering method, a method based on cluster prototypes for individual outlier measurements and a method based on cluster prototypes for entire growth trajectories. Each method was applied individually and evaluated using the sensitivity and specificity indexes based on the manually introduced outliers. We also calculated the Kappa statistic to evaluate the agreement of each method against the manual outliers.

Results

After excluding premature (&lt;37 weeks), low birth weight (&lt;1500 g) neonates and children with missing length and weight measurements, we analyzed 393 children with a total of 3144 measurements. Sensitivity and specificity for the four methods ranged between 4.4%–55.0% and 83.7% −99.7%, respectively, with kappa being non-significant (P &gt; 0.05) only for the empirical. The clustering detection method reported a higher finding rate, while the empirical method found most of the BIV, but few of the rest of the outliers.

Conclusions

BIV account for a small portion of the possible outliers in growth datasets. We show that additional statistical or model-based methods are required for a more comprehensive outlier detection process, which has implications for growth analysis and nutritional assessment.

Funding Sources

Joannah and Brian Lawson Center for Child Nutrition, Connaught Fund, Onassis Foundation.

Metabolomic Profiles Associated with Mortality of Children with Complicated Severe Malnutrition: A Nested Case-Control Study

Objectives

Children hospitalized with complicated severe malnutrition (CSM) have unacceptably high mortality rates despite receiving standard nutritional and medical treatment. The underlying pathology of the poor prognosis is not well understood. Growing evidence indicates presence of metabolic dysfunction in CSM. Yet, it is unclear whether and how metabolic dysfunction contributes the poor prognosis. This study aimed to identify metabolic signatures and pathways associated with CSM mortality.

Methods

A case-control study was performed on CSM patients enrolled to a multicenter (one Malawi and two Kenya hospitals) randomized control trial (NCT02246296). A total of 90 death cases and 90 discharged controls that were propensity score matched by age, HIV and mid-upper arm circumferences were included in the study. Targeted metabolomics was performed on their serum samples collected at admission and on day 3 of hospitalization. In particular, 206 metabolites, including amino acids, acylcarnitines, lipids and organic acids were quantified by LC-MS/MS.

Results

Discriminant analysis (PLS-DA) showed that metabolomic signatures at admission could differentiate cases from controls, with a cross-validated classification error rate of 21.8%. An increase of homovanillic, isobutyric and propionic acids, and decrease of lipids lysoPC a C18:2, lysoPC a C20:4, PC ae C42:2, SM C26:0, and SM C26:1 were the top 8 significant features characterizing the admission metabolomes of cases. Notably, cases with higher levels of isobutyrate, a microbial fermentation product, had significantly shorter survival time, implying a role of gut integrity in mortality. Pathway analysis revealed that metabolites of the tricarboxylic acid (TCA) cycle pathway differentiated cases from controls. Analysis of day 3 samples showed metabolic differences in response to treatment, especially in the recovery rate of lipids, between cases and controls.

Conclusions

CSM non-survivors have metabolomes distinct from survivors indicating perturbations in mitochondrial function and nutrition utilization. Perturbed metabolites identified shed light on biological mechanisms of mortality and may serve as targets of nutritional or therapeutic interventions to improve CSM survival.

Funding Sources

Bill and Melinda Gates Foundation, Thrasher Research Fund, and RESTRACOMP Graduate Scholarship.

Discrepant Inferences When Modeling Associations Between Time-Varying Exposures and Linear Growth Trajectories in Infancy Using Length-For-Age Z Scores Versus Raw Length

Objectives

To compare inferences from longitudinal models of the relationships between biomarkers of interest and linear growth outcomes in infancy using length-for-age z-scores (LAZ) based on age- and sex-specific growth standards, or raw length.

Methods

This was a secondary analysis of data from a study of the association between bone-related biomarkers and infant linear growth trajectories up to 1 year of life in a subset of infants (n = 820) enrolled in the Maternal Vitamin D for Infant Growth trial. The linear growth outcome (LAZ or raw length) was modelled as a function of the interaction between each biomarker and age using linear mixed effect models with restricted cubic splines. Models were specified to obtain the best fit and reconcile discrepancies in results from LAZ and length models. Inferences from marginal effects at birth, 3 months, 6 months, and 12 months were compared, for a total 4 effect estimates from each of 10 pairs of LAZ and length models, resulting in 40 pairs of estimates. The following biomarkers were included: fibroblast growth factor 21 (FGF21), fibroblast growth factor 23 (FGF23), N-terminal propeptide of C-type natriuretic peptide (NT-proCNP), osteocalcin, osteoprotegerin, receptor activator of nuclear activator kappa-b ligand (RANKL), 25-hydroxyvitamin D (25OHD), C-reactive protein (CRP), Interleukin 6 (IL6), and insulin-like growth factor-1 (IGF1). Biomarkers were time-varying, measured in cord blood and at 3 and 6 months of age.

Results

The best fitting model for LAZ had 3 knots with random slopes, and the best fitting model for raw length had 5 knots, random slopes, and an exponential residual covariance structure. Comparisons of the pairs of marginal estimates from the LAZ vs length models resulted in discrepant inferences for 25% of effect estimates (10/40). Results were consistently concordant only for FGF23, 25OHD, CRP, and IL6.

Conclusions

Length and LAZ represent the same biological construct but their use in longitudinal modelling may lead to different inferences about associations between time-varying exposures and infant growth, possibly due to residual confounding by age. These findings raise concerns about the reliability of studies of determinants or markers of infant linear growth based on longitudinal modelling of growth trajectories.

Funding Sources

Bill and Melinda Gates Foundation.

The Role of Tryptophan-Nicotinamide (TRP-NAM) Pathway in Malnutrition Induced Liver Dysfunction

Objectives

Malnutrition contributes to 45% of the deaths of children &lt; 5. Mortality in severe malnutrition is often related to metabolic disturbances, including hypoglycemia, indicating hepatic metabolic dysfunction. Children with severe malnutrition have been found to have significantly lower circulating tryptophan (TRP) levels in their blood. Disturbances in TRP-NAM pathway have been implicated in liver and intestine diseases, potentially mediated by NAD-dependent deacetylase SIRT1. This study aim to evaluate the effect of modulating TRP-NAM pathway on hepatic metabolism dysfunction in a mouse model of severe malnutrition.

Methods

Weanling male C57BL/6J mice were randomized into different groups fed with a control diet (18% protein), or a malnourished diet (1% protein) with or without supplementation of modulators of the TRP-NAM pathway (NAM, NR and TRP). Supplementation therapies were given from days 7–14 after start of the dietary intervention. In addition, SIRT1 modulators treatment including resveratrol, EX-527 and vehicle were tested. Comprehensive metabolic, histological and molecular analyses were performed.

Results

After diet treatment, the mice in the 1% protein group had significantly lower body weight and body length compared to the 18% protein group, without any effect of modulators of the TRP-NAM pathway. Feeding mice a 1% protein diet led to severe hepatic steatosis, mitochondrial structural alterations, lower ATP levels, disrupted TRP-NAM pathway metabolites, and a decrease of phospholipids to triglycerides ratio. NAM, NR and TRP treatment all led to a partial reversal of the hepatic steatosis in the 1% protein-fed mice. ATP levels, mtDNA copy number, and PPARα target genes in the β-oxidation pathway were also recovered in treatment group. We postulate that the effect is mediated through changes in levels of NAD+, which is critical in redox reactions and is a substrate for SIRT1, important for mitochondrial function.

Conclusions

Modulating TRP-NAM pathway can partially improve liver metabolic function in a mouse model of severe malnutrition. This study improves our understanding of the cellular pathophysiology of severe malnutrition. The results of this project could lead to the development of new interventions which could then be taken to clinical trials.

Funding Sources

Bill & Melinda Gates Foundation.

Urinary Organic Acids Increase After Clinical Stabilization of Hospitalized Children With Severe Acute Malnutrition

BACKGROUND

Despite a reduction of child mortality in low-income countries, acutely ill undernourished children still have an elevated risk of death. Those at highest risk are children with severe acute malnutrition (SAM) who often show metabolic dysregulation that remains poorly understood.

OBJECTIVE

We performed a pilot study to examine changes in urinary organic acids during nutritional rehabilitation of children with SAM, and to identify metabolites associated with the presence of edema or with mortality.

METHODS

This study included 76 children aged between 6 and 60 months, hospitalized for SAM at the Moyo Nutritional Rehabilitation and Research Unit in Blantyre, Malawi. Urine was collected at admission and 3 days after clinical stabilization and metabolomics were performed using gas chromatography-mass spectrometry. Metabolite concentrations were evaluated with both uni- and multivariate approaches.

RESULTS

Most metabolites increased 3 days after clinical stabilization, and total urinary concentration changed from 1.2 mM (interquartile range [IQR], 0.78-1.7) at admission to 3.8 mM (IQR, 2.1-6.6) after stabilization (P < .0001). In particular, 6 metabolites showed increases: 3-hydroxybutyric, 4-hydroxyhippuric, p-hydroxyphenylacetic, oxoglutaric, succinic, and lactic acids. Urinary creatinine was low at both time points, but levels did increase from 0.63 mM (IQR, 0.2-1.2) to 2.6 mM (IQR,1.6-4.4; P < .0001). No differences in urinary profiles were found between children who died versus those who survived, nor between children with severe wasting or edematous SAM.

CONCLUSIONS

Total urinary metabolites and creatinine increase after stabilization and may reflect partial recovery of overall metabolism linked to refeeding. The use of urinary metabolites for risk assessment should be furthered explored.

TRIAL REGISTRATION

TranSAM study (ISRCTN13916953).

Metabolomics in plasma of Malawian children 7 years after surviving severe acute malnutrition: "ChroSAM" a cohort study

BACKGROUND

More children are now surviving severe acute malnutrition (SAM), but evidence suggests that early-life malnutrition is associated with increased risk of long-term cardio-metabolic disorders. To better understand potential mechanisms, we studied the metabolite profiles of children seven years after treatment for SAM.

METHODS

We followed-up children (n = 352) treated for SAM in 2006-2007, at Queen Elizabeth Central Hospital, in Malawi. Using nuclear magnetic resonance spectroscopy, tandem mass spectrometry and enzyme-linked immunosorbent assay, we measured circulating metabolites in fasting blood in a subset of SAM survivors (n = 69, 9·6 ± 1·6 years), siblings (n = 44, 10·5 ± 2·7 years), and age and sex-matched community controls (n = 37, 9·4 ± 1·8 years). Data were analysed using univariate and sparse partial least square (sPLS) methods. Differences associated with SAM survival, oedema status, and anthropometry were tested, adjusting for age, sex, HIV, and wealth index.

FINDINGS

Based on 194 measured metabolites, the profiles of SAM survivors were similar to those of siblings and community controls. IGF1, creatinine, and FGF21, had loading values >0·3 and ranked stably in the top 10 distinguishing metabolites, but did not differ between SAM survivors and controls with univariate analysis. Current stunting was associated with IGF1 (β = 15·2, SE = 3·5, partial R2 = 12%, p < 0·0001) and this relationship could be influenced by early childhood SAM (β = 17·4, SE = 7·7, partial R2 = 2·8%, p = 0·025). No metabolites were associated with oedema status, duration of hospital stay, anthropometry measured during hospitalization, nor with changes in anthropometry since hospitalization.

INTERPRETATION

In this group of survivors, SAM was not associated with longer-term global metabolic changes 7 years after treatment. However, SAM may influence the relationship between current stunting and IGF1. Further risk markers for NCDs in SAM survivors may only be revealed by direct metabolic challenge or later in life.

Association of Bone Metabolism Biomarkers with Infant Linear Growth in a Birth Cohort from Dhaka, Bangladesh (P10-012-19)

Objectives

To estimate the associations of venous cord, infant 3-month, and 6-month bone-related biomarker concentrations (amino-terminal propeptide of C-type natriuretic peptide [NT-proCNP], fibroblast-like growth factor 21 [FGF21], receptor activator of nuclear activator kappa-b ligand [RANKL], osteoprotegerin [OPG], 25-hydroxyvitamin D [25OHD], FGF23, osteocalcin [OC], and insulin-like growth factor 1 [IGF-I]) with infant length-for-age z-score (LAZ) trajectories from 0 to 12 months of age, in Dhaka, Bangladesh.

Methods

This was a sub-study of the Maternal Vitamin D for Infant Growth trial in Dhaka, Bangladesh. NT-proCNP, FGF21, FGF23, and IGF-I were measured by ELISA, 25OHD by HPLC-tandem mass spectrometry, and OC, OPG, and RANKL by Milliplex magnetic panels. The primary outcome was LAZ from birth to 12 months of age. Among eligible infants (n = 569), associations between each biomarker and LAZ were estimated by linear mixed-effects models with restricted cubic splines. Significant biomarker-age interaction terms were interpreted as evidence of associations of the biomarker with postnatal growth (PG) trajectory. Marginal effects at discrete ages were estimated based on the fitted model.

Results

25OHD was associated with PG (P = 0.022), with a negative association with LAZ at birth, but no association at subsequent time points. IGF1 and RANKL were both significantly associated with PG (pIGF1 < 0.001; pRANKL = 0.022), were not associated with LAZ at birth, but were positively associated with LAZ at subsequent time points. OC was associated with PG (P < 0.001), was negatively associated with LAZ at birth, and was positively associated with LAZ at 12 months. NT-proCNP was associated with postnatal LAZ trajectories (P < 0.001), with negative associations with LAZ at 3 and 6 months of age, but no association at 12 months. There was no significant association between FGF21 and PG; however, FGF21 was consistently negatively associated with LAZ. OPG and FGF23 were not associated with PG.

Conclusions

Several serum/plasma biomarkers were associated with infant linear growth in a cohort from Bangladesh. IGF1, RANKL, and OC were most strongly associated postnatal LAZ growth. FGF21 was not associated with PG but was associated with fetal linear growth with sustained effects in the postnatal period.

Funding Sources

Funded by the Bill and Melinda Gates Foundation.

Maternal Body Mass Index and Breastmilk Energy, Fat, and Protein Content: A Systematic Review and Regression Analysis of Simulated Data (OR30-06-19)

Objectives

Given increased incidence of maternal postpartum obesity and limited understanding of the degree to which maternal body composition is related to energy and macronutrient content of breastmilk, we conducted a systematic review to assess the associations between maternal body mass index (BMI) and breastmilk energy, fat, and/or total protein content.

Methods

A protocol was registered prior to the completion of this systematic review (PROSPERO 2018 CRD42018098808). The electronic databases MEDLINE, Embase, CINAHL, and Web of Science were searched. The three outcomes of interest were breastmilk energy (kcal/dL), fat (g/dL), and total protein (g/dL) from mothers of term-born infants. Articles that reported maternal BMI or weight and height, collected breastmilk, and measured energy, fat, or protein concentration in breastmilk one to six months postpartum were eligible. If breastmilk was collected at multiple timepoints, the measures closest to three months postpartum were used. A simulated dataset was generated in Stata 14 based on respective sample sizes and means and variance of maternal BMI and breastmilk energy, fat, and protein content of the included studies, assuming normality of each of these variables based on the literature. Linear regressions were performed to examine associations between maternal BMI (kg/m2) and breastmilk energy and individual macronutrients.

Results

A total of 2,012 articles were identified from the search and reference lists of included studies. After full-text screening by two reviewers, 39 articles were included with breastmilk samples from 2,837 mothers. Based on the simulated data, maternal BMI was not significantly associated with breastmilk energy concentration (β = −0.0044, 95% CI [−0.14, 0.14], P > 0.9). However, BMI was positively associated with breastmilk fat concentration (β = 0.015, 95% CI [0.0022, 0.027] P = 0.02) and was negatively associated with total protein concentration (β = −0.0068, 95% CI [−0.011, −0.0027], P = 0.001). Thus, every 1 kg/m2 increase in BMI is associated with a 0.0022 g/dL increase in fat and a 0.011 g/dL decrease in total protein concentration.

Conclusions

Statistically significant associations were found between maternal BMI and breastmilk fat and protein content. However, the effect size was small suggesting that these differences may not be clinically meaningful.

Funding Sources

N/A.

Supporting Tables, Images and/or Graphs

Health Professionals' Perceptions of a Pediatric Nutrition Support Program Led by a Clinical Dietitian at a Low-resource Hospital Setting in Malawi (P12-028-19)

Objectives

The first four dietitians graduated in Malawi in 2017, providing a new opportunity to build capacity to introduce nutrition support in an acute care setting. We designed and implemented a pediatric nutrition support program at Queen Elizabeth Central Hospital (QECH) in Blantyre, Malawi including the hiring of a local dietitian in August 2018. Upon introducing this program, we aimed to qualitatively assess perceptions around the nutrition support program from the perspective of health professionals at QECH.

Methods

Qualitative interviews using a narrative research approach were undertaken to understand perceptions about the nutrition support program. Participants were selected through a purposive sampling approach across the eight wards within the nutrition support program at QECH. Interviews were held with nurses (n = 5) and clinicians and surgeons (n = 11) at QECH in November and December 2018. These interviews were audio-recorded before being transcribed and themes were then coded inductively using NVivo 11 software.

Results

All participants of the qualitative interviews emphasized the importance and impact of the nutrition support program in enhancing care of hospitalized children and therefore improving child outcomes such as tolerability of clinical interventions, decreased duration of stay, and reduced risk of hospital readmission. Other themes that arose were the receptiveness of guardians of children who received nutrition support, the importance of engaging other health professionals in nutrition support, and the need for prioritization of nutrition support by the Ministry of Health to sustain and scale up this type of program in Malawi.

Conclusions

Qualitative interviews with nurses, clinicians, and surgeons highlighted the value of nutrition support to improve quality of care in low-resource hospital settings. Integration of dietitians into the healthcare system in low- and middle-income countries like Malawi will require further advocacy around the potential for nutrition support to improve outcomes in vulnerable children.

Funding Sources

The introduction of the nutrition support program was funded by the Centre for Global Child Health Catalyst Grant from the Hospital for Sick Children.

Developmental and behavioural problems in children with severe acute malnutrition in Malawi: A cross-sectional study

Background

Early childhood development provides an important foundation for the development of human capital. Although there is a clear relation between stunting and child development outcomes, less information is available about the developmental and behavioural outcomes of children with severe acute malnutrition (SAM). Particularly an important research gap exists in Sub–Saharan Africa where there is a high prevalence of SAM and a high rate of co–occurring HIV (human immune deficiency virus) infection. Our first objective was to assess the prevalence and severity of developmental and behavioural disorders on a cohort of children admitted to an inpatient nutritional rehabilitation centre in Malawi. Our second objective was to compare the developmental and behavioural profiles of children with the two main phenotypes of SAM: kwashiorkor and marasmus.

Methods

This was a cross–sectional observational study including all children hospitalized with complicated SAM in Blantyre, Malawi over an 8–month period from February to October 2015. At discharge, children were assessed with the well-validated Malawi Developmental Assessment Tool (MDAT) for gross motor, fine motor, language and social development. In children ≥24 months, emotional and behavioural problems were measured using the Strengths and Difficulties Questionnaire (SDQ).

Results

150 children (55% boys) with SAM were recruited; mean age of 27.2 months (standard deviation 17.9), 27 children (18%) had pre–existing neurodisabilities (ND) and 34 (23%) had a co–occurring human immune deficiency virus (HIV) infection. All children with SAM experienced profound delays in the gross and fine motor, language and social domains. Linear regression analysis demonstrated that children with kwashiorkor scored 0.75 standard deviations lower (95% confidence interval –1.43 to –0.07) on language MDAT domain than children with marasmus when adjusted for covariates. The prosocial behaviour score of the SDQ was low in children with SAM, indicating a lack of sensitive behaviour in social interactions.

Conclusions

Children with SAM have severe developmental delays after a hospital admission. Our results indicate that there might be a significant difference in developmental attainment between children with kwashiorkor and with marasmus. Future studies exploring longer–term outcomes and testing possible intervention strategies are urgently needed.

Stool frequency recording in severe acute malnutrition ('StoolSAM'); an agreement study comparing maternal recall versus direct observation using diapers

Background

Approximately 50% of the deaths of children under the age of 5 can be attributed to undernutrition, which also encompasses severe acute malnutrition (SAM). Diarrhoea is strongly associated with these deaths and is commonly diagnosed solely based on stool frequency and consistency obtained through maternal recall. This trial aims to determine whether this approach is equivalent to a ‘directly observed method’ in which a health care worker directly observed stool frequency using diapers in hospitalised children with complicated SAM.

Methods

This study was conducted at ‘Moyo’ Nutritional Rehabilitation Unit, Queen Elizabeth Central Hospital, Malawi. Participants were children aged 5–59 months admitted with SAM. We compared 2 days of stool frequency data obtained with next-day maternal-recall versus a ‘gold standard’ in which a health care worker observed stool frequency every 2 h using diapers. After study completion, guardians were asked their preferred method and their level of education.

Results

We found poor agreement between maternal recall and the ‘gold standard’ of directly observed diapers. The sensitivity to detect diarrhoea based on maternal recall was poor, with only 75 and 56% of diarrhoea cases identified on days 1 and 2, respectively. However, the specificity was higher with more than 80% of children correctly classified as not having diarrhoea. On day 1, the mean stool frequency difference between the two methods was −0.17 (SD; 1.68) with limits of agreement (of stool frequency) of −3.55 and 3.20 and, similarly on day 2, the mean difference was −0.2 (SD; 1.59) with limits of agreement of −3.38 and 2.98. These limits extend beyond the pre-specified ‘acceptable’ limits of agreement (±1.5 stool per day) and indicate that the 2 methods are non-equivalent. The higher the stool frequency, the more discrepant the two methods were. Most primary care givers strongly preferred using diapers.

Conclusions

This study shows lack of agreement between the assessment of stool frequency in SAM patients using maternal recall and direct observation of diapers. When designing studies, one should consider using diapers to determining diarrhoea incidence/prevalence in SAM patients especially when accuracy is essential.

Trial registration number

ISRCTN11571116 (registered 29/11/2013).

Electronic supplementary material

The online version of this article (doi:10.1186/s12887-017-0874-0) contains supplementary material, which is available to authorized users.

PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation

Sargent et al. identify the E3 ubiquitin ligase PEX2 as the causative agent of mammalian pexophagy. During amino acid starvation, PEX2 expression increases to ubiquitinate peroxisomal membrane proteins and signal peroxisome degradation by autophagy.

Peroxisomes are metabolic organelles necessary for anabolic and catabolic lipid reactions whose numbers are highly dynamic based on the metabolic need of the cells. One mechanism to regulate peroxisome numbers is through an autophagic process called pexophagy. In mammalian cells, ubiquitination of peroxisomal membrane proteins signals pexophagy; however, the E3 ligase responsible for mediating ubiquitination is not known. Here, we report that the peroxisomal E3 ubiquitin ligase peroxin 2 (PEX2) is the causative agent for mammalian pexophagy. Expression of PEX2 leads to gross ubiquitination of peroxisomes and degradation of peroxisomes in an NBR1-dependent autophagic process. We identify PEX5 and PMP70 as substrates of PEX2 that are ubiquitinated during amino acid starvation. We also find that PEX2 expression is up-regulated during both amino acid starvation and rapamycin treatment, suggesting that the mTORC1 pathway regulates pexophagy by regulating PEX2 expression levels. Finally, we validate our findings in vivo using an animal model.

Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study

BACKGROUND

Tackling severe acute malnutrition (SAM) is a global health priority. Heightened risk of non-communicable diseases (NCD) in children exposed to SAM at around 2 years of age is plausible in view of previously described consequences of other early nutritional insults. By applying developmental origins of health and disease (DOHaD) theory to this group, we aimed to explore the long-term effects of SAM.

METHODS

We followed up 352 Malawian children (median age 9·3 years) who were still alive following SAM inpatient treatment between July 12, 2006, and March 7, 2007, (median age 24 months) and compared them with 217 sibling controls and 184 age-and-sex matched community controls. Our outcomes of interest were anthropometry, body composition, lung function, physical capacity (hand grip, step test, and physical activity), and blood markers of NCD risk. For comparisons of all outcomes, we used multivariable linear regression, adjusted for age, sex, HIV status, and socioeconomic status. We also adjusted for puberty in the body composition regression model.

FINDINGS

Compared with controls, children who had survived SAM had lower height-for-age Z scores (adjusted difference vs community controls 0·4, 95% CI 0·6 to 0·2, p=0·001; adjusted difference vs sibling controls 0·2, 0·0 to 0·4, p=0·04), although they showed evidence of catch-up growth. These children also had shorter leg length (adjusted difference vs community controls 2·0 cm, 1·0 to 3·0, p<0·0001; adjusted difference vs sibling controls 1·4 cm, 0·5 to 2·3, p=0·002), smaller mid-upper arm circumference (adjusted difference vs community controls 5·6 mm, 1·9 to 9·4, p=0·001; adjusted difference vs sibling controls 5·7 mm, 2·3 to 9·1, p=0·02), calf circumference (adjusted difference vs community controls 0·49 cm, 0·1 to 0·9, p=0·01; adjusted difference vs sibling controls 0·62 cm, 0·2 to 1·0, p=0·001), and hip circumference (adjusted difference vs community controls 1·56 cm, 0·5 to 2·7, p=0·01; adjusted difference vs sibling controls 1·83 cm, 0·8 to 2·8, p<0·0001), and less lean mass (adjusted difference vs community controls -24·5, -43 to -5·5, p=0·01; adjusted difference vs sibling controls -11·5, -29 to -6, p=0·19) than did either sibling or community controls. Survivors of SAM had functional deficits consisting of weaker hand grip (adjusted difference vs community controls -1·7 kg, 95% CI -2·4 to -0·9, p<0·0001; adjusted difference vs sibling controls 1·01 kg, 0·3 to 1·7, p=0·005,)) and fewer minutes completed of an exercise test (sibling odds ratio [OR] 1·59, 95% CI 1·0 to 2·5, p=0·04; community OR 1·59, 95% CI 1·0 to 2·5, p=0·05). We did not detect significant differences between cases and controls in terms of lung function, lipid profile, glucose tolerance, glycated haemoglobin A1c, salivary cortisol, sitting height, and head circumference.

INTERPRETATION

Our results suggest that SAM has long-term adverse effects. Survivors show patterns of so-called thrifty growth, which is associated with future cardiovascular and metabolic disease. The evidence of catch-up growth and largely preserved cardiometabolic and pulmonary functions suggest the potential for near-full rehabilitation. Future follow-up should try to establish the effects of puberty and later dietary or social transitions on these parameters, as well as explore how best to optimise recovery and quality of life for survivors.

FUNDING

The Wellcome Trust.

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

Background & Aims

Non-alcoholic fatty liver disease (NAFLD) is characterized by dysbiosis. The bidirectional effects between intestinal microbiota (IM) and bile acids (BA) suggest that dysbiosis may be accompanied by an altered bile acid (BA) homeostasis, which in turn can contribute to the metabolic dysregulation seen in NAFLD. This study sought to examine BA homeostasis in patients with NAFLD and to relate that with IM data.

Methods

This was a prospective, cross-sectional study of adults with biopsy-confirmed NAFLD (non-alcoholic fatty liver: NAFL or non-alcoholic steatohepatitis: NASH) and healthy controls (HC). Clinical and laboratory data, stool samples and 7-day food records were collected. Fecal BA profiles, serum markers of BA synthesis 7-alpha-hydroxy-4-cholesten-3-one (C4) and intestinal BA signalling, as well as IM composition were assessed.

Results

53 subjects were included: 25 HC, 12 NAFL and 16 NASH. Levels of total fecal BA, cholic acid (CA), chenodeoxycholic acid (CDCA) and BA synthesis were higher in patients with NASH compared to HC (p<0.05 for all comparisons). The primary to secondary BA ratio was higher in NASH compared to HC (p = 0.004), but ratio of conjugated to unconjugated BAs was not different between the groups. Bacteroidetes and Clostridium leptum counts were decreased in in a subset of 16 patients with NASH compared to 25 HC, after adjusting for body mass index and weight-adjusted calorie intake (p = 0.028 and p = 0.030, respectively). C. leptum was positively correlated with fecal unconjugated lithocholic acid (LCA) (r = 0.526, p = 0.003) and inversely with unconjugated CA (r = -0.669, p<0.0001) and unconjugated CDCA (r = - 0.630, p<0.0001). FGF19 levels were not different between the groups (p = 0.114).

Conclusions

In adults with NAFLD, dysbiosis is associated with altered BA homeostasis, which renders them at increased risk of hepatic injury.

Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort

BACKGROUND & AIMS

Proprotein convertase 1/3 (PC1/3) deficiency, an autosomal-recessive disorder caused by rare mutations in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene, has been associated with obesity, severe malabsorptive diarrhea, and certain endocrine abnormalities. Common variants in PCSK1 also have been associated with obesity in heterozygotes in several population-based studies. PC1/3 is an endoprotease that processes many prohormones expressed in endocrine and neuronal cells. We investigated clinical and molecular features of PC1/3 deficiency.

METHODS

We studied the clinical features of 13 children with PC1/3 deficiency and performed sequence analysis of PCSK1. We measured enzymatic activity of recombinant PC1/3 proteins.

RESULTS

We identified a pattern of endocrinopathies that develop in an age-dependent manner. Eight of the mutations had severe biochemical consequences in vitro. Neonates had severe malabsorptive diarrhea and failure to thrive, required prolonged parenteral nutrition support, and had high mortality. Additional endocrine abnormalities developed as the disease progressed, including diabetes insipidus, growth hormone deficiency, primary hypogonadism, adrenal insufficiency, and hypothyroidism. We identified growth hormone deficiency, central diabetes insipidus, and male hypogonadism as new features of PCSK1 insufficiency. Interestingly, despite early growth abnormalities, moderate obesity, associated with severe polyphagia, generally appears.

CONCLUSIONS

In a study of 13 children with PC1/3 deficiency caused by disruption of PCSK1, failure of enteroendocrine cells to produce functional hormones resulted in generalized malabsorption. These findings indicate that PC1/3 is involved in the processing of one or more enteric hormones that are required for nutrient absorption.